Literature DB >> 30259516

A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.

Adili Keranmu1,2, Hai-Ning Liu3, Yu-Chen Wu1,2, Tao-Tao Liu3, Cong Li1,2, Tian-An Guo1,2, Fang-Qi Liu1,2, Hong-Tu Zheng1,2, Ye Xu1,2.   

Abstract

AIM: Many issues relating to the distal margin of anterior resection of the rectum still exist. We aimed to investigate whether negative distal resection margin (DRM) and positive DRM in the main specimen with negative doughnut has equivalent prognosis in patients with rectal cancer.
METHODS: We included 287 patients with rectal cancer, including 69 cases with positive margins and 218 cases with negative margins, all of whom underwent regular follow-up. Survival rate was calculated using Kaplan-Meier survival analysis, while the log-rank test was used to determine statistical difference. Prognostic factors were found using the Cox regression model.
RESULTS: There was no significant difference in clinicopathological features between the two groups with the exception of tumor location. Positive findings in the DRM with negative findings in the doughnut resection do not affect the overall survival, local recurrence, or distant metastasis. Factors relating to resection margin, such as the length of resection, negative, or positive findings, were not found to be prognostic.
CONCLUSION: Given postoperative pathology results with positive DRM but negative findings in the doughnut resection, a second surgery was not necessary. Instead, adjuvant radiochemotherapy and close follow-up will suffice.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  anterior resection; distal resection margin; overall survival; rectal neoplasms

Mesh:

Year:  2018        PMID: 30259516     DOI: 10.1002/jso.25161

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.

Authors:  Yi-Hung Kuo; Chia-Hsuan Lai; Cheng-Yi Huang; Chih-Jung Chen; Yun-Ching Huang; Wen-Shih Huang; Chih-Chien Chin
Journal:  BMC Cancer       Date:  2019-08-17       Impact factor: 4.430

2.  Evaluation of the learning curve for conformal sphincter preservation operation in the treatment of ultralow rectal cancer.

Authors:  Hai-Bo Ding; Lin-Hui Wang; Ge Sun; Guan-Yu Yu; Xian-Hua Gao; Kuo Zheng; Hai-Feng Gong; Jin-Ke Sui; Xiao-Ming Zhu; Wei Zhang
Journal:  World J Surg Oncol       Date:  2022-03-30       Impact factor: 2.754

3.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

4.  Routine pathologic evaluation of circular stapler anastomotic rings is not useful after resection for colorectal cancer: retrospective study and systematic review with meta-analysis.

Authors:  James R Holden; Pam McIntosh; Garrett G R J Johnson; Jason Park; David J Hochman; Ashley Vergis; Benson Yip; Ramzi M Helewa; Eric Hyun
Journal:  BJS Open       Date:  2022-09-02

5.  Precision functional sphincter-preserving surgery (PPS) for ultralow rectal cancer: a natural orifice specimen extraction (NOSE) surgery technique.

Authors:  Cheng-Le Zhuang; Feng-Min Zhang; Zheng Wang; Xun Jiang; Feng Wang; Zhong-Chen Liu
Journal:  Surg Endosc       Date:  2020-09-28       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.